Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Jul;53(7):e2250162.
doi: 10.1002/eji.202250162. Epub 2023 May 8.

Clonally expanded PD-1-expressing T cells are enriched in synovial fluid of juvenile idiopathic arthritis patients

Affiliations
Free article
Comment

Clonally expanded PD-1-expressing T cells are enriched in synovial fluid of juvenile idiopathic arthritis patients

Anna Vanni et al. Eur J Immunol. 2023 Jul.
Free article

Abstract

Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic condition in childhood. The disease etiology remains largely unknown; however, a key role in JIA pathogenesis is surely mediated by T cells. T-lymphocytes activity is controlled via signals, known as immune checkpoints. Delivering an inhibitory signal or blocking a stimulatory signal to achieve immune suppression is critical in autoimmune diseases. However, the role of immune checkpoints in chronic inflammation and autoimmunity must still be deciphered. In this study, we investigated at the single-cell level the feature of T cells in JIA chronic inflammation, both at the transcriptome level via single-cell RNA sequencing and at the protein level by flow cytometry. We found that despite the heterogeneity in the composition of synovial CD4+ and CD8+ T cells, those characterized by PD-1 expression were clonally expanded tissue-resident memory (Trm)-like cells and displayed the highest proinflammatory capacity, suggesting their active contribution in sustaining chronic inflammation in situ. Our data support the concept that novel therapeutic strategies targeting PD-1 may be effective in the treatment of JIA. With this approach, it may become possible to target overactive T cells regardless of their cytokine production profile.

Keywords: Immune checkpoints ⋅ Inflammation ⋅ Juvenile Idiopathic Arthritis ⋅ T cells ⋅ PD-1.

PubMed Disclaimer

Comment on

References

    1. Ravelli, A. and Martini, A., Juvenile idiopathic arthritis. Lancet. 2007. 369: 767-778.
    1. Barut, K., Adrovic, A. and Şahin, S., Kasapçopur, Ö., Juvenile idiopathic arthritis. Balkan Med J. 2017. 34: 90-101.
    1. Cimaz, R., Marino, A. and Martini, A., How I treat juvenile idiopathic arthritis: a state of the art review. Autoimmun. Rev. 2017. 16: 1008-1015.
    1. Hinks, A., Cobb, J., Marion, M. C., Prahalad, S., Sudman, M., Bowes, J., Martin, P. et al., Dense genotyping of immune-related disease regions identifies 14 new susceptibility loci for juvenile idiopathic arthritis. Nat. Genet. 2013. 45: 664-669.
    1. McIntosh, L. A., Marion, M. C., Sudman, M., Comeau, M. E., Becker, M. L., Bohnsack, J. F., Fingerlin, T. E. et al., Genome-wide association meta-analysis reveals novel juvenile idiopathic arthritis susceptibility loci. Arthritis Rheumatol. 2017. 69: 2222-2232.

Publication types

Substances